Skip to search.
 All Ordinaries Up 0.61%

More On NBS

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Neostem, Inc. (NBS)

-NasdaqCM
2.25 0.00(0.00%) 6 Jun 05:59
Add to Portfolio
Prev Close:2.25
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:13.50
Beta:1.37
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:2.03 - 7.23
Volume:0
Avg Vol (3m):760,553
Market Cap:116.83M
P/E (ttm):N/A
EPS (ttm):-1.72
Div & Yield:0.06 (1.00%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NeoStem, Inc., a clinical-stage biopharmaceutical company, develops cell based therapeutics in the United States. It is developing NBS20, a targeted cancer immunotherapy product that is in Phase III clinical trials for the treatment of metastatic ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback